ASX 200 falls 30 points to 7615 (0.4%) as a CSL drug trial fails. A Phase III trial for CSL saw the stock down 4.8% with RMD off 1.4%. Industrials solid with good results from JBH lifting the retail sector, JBH up 7.1% APE up 2.2% and LOV up 4.8%. WES and supermarkets fail to fire, Tech slightly firmer, XRO up 1.5% and WTC rallying 0.5% with the All-Tech Index up 1.1%.  Banks solid on ANZ Basel update, the Big Bank Basket up to $200.92 (0.1%). CBA down 0.4% ahead of numbers Wednesday, ANZ star up 1.3%. MQG slid 1.4% with GQG down 1.9%. Resources weaker again despite Lunar New Year, BHP down 0.5% and RIO off 0.7% with lithium off again, PLS down 2.5% and S32 falling 1.6%. Gold miners slightly easier, WDS dropped 2.2% and BPT up 3.3% on results. In corporate news, AZJ reported better than expected numbers, SM1 fell 15.1% on a profit warning, APX rose 16.1% as it moved to cut US costs.  Nothing on the economic front today. 10-year yields up to 4.15%. Japan barely changed.

Why not sign up for a free trial? Get access to expert insights and research and become a better investor.

Make life simple. Invest with Marcus Today.